Market Recap - Talk Of 2016 Fed Interest Rate Increases Continue
Must be a valid email address.
Password must be 8-64 characters.
Must be a valid phone number.
Recession incoming? Here’s how you can prepare.
Daily Capital
Home>Daily Capital>Investing & Markets>Market Recap – Talk Of 2016 Fed Interest Rate Increases Continues

Market Recap – Talk Of 2016 Fed Interest Rate Increases Continues

Market Digest – Week Ending 3/24

Stocks failed to achieve a sixth consecutive weekly advance. An increasing view that the Fed will follow-through with multiple rate increases in 2016 drove the dollar higher and sapped enthusiasm for stocks, commodities and emerging market assets. The S&P 500 lost 0.6% in a short week. Markets will be closed for Good Friday. A horrific terror attack in Brussels, just three months after the Paris attacks, heightened tensions but did not have a significant immediate impact on markets.

Weekly Returns:

S&P 500: 2,036 (-0.6%)
FTSE All-World ex-US: (-1.9%)
US 10 Year Treasury Yield: 1.90% (+0.01%)
Gold: $1,217 (-3.0%)
USD/EUR: $1.118 (-0.9%)

Major Events:

• Monday – Moody’s Investors Service said it is reviewing Deutsche Bank AG’s credit rating for possible downgrade.
• Monday – Sales of previously owned homes sank 7.1% in February, a sign that demand for housing could be cooling amid rising prices and low inventory.
• Tuesday – Terrorists detonated bombs in the main airport and a metro station in Brussels, killing at least 31 people. ISIS claimed responsibility.
• Tuesday – Donald Trump and Hillary Clinton won primaries in Arizona, maintaining front-runner status. Ted Cruz won Utah and Bernie Sanders won Utah and Idaho.
• Wednesday – It was reported that regulators plan to require banks to hold back much of an executive’s bonus beyond the three years already adopted by many firms.
• Thursday – Hedge fund Starboard Value LP said it hopes to remove the entire Yahoo board.

Our take:

For millennials, “Valeant” may replace “Enron” as the go-to example of a big, evil company bust. The pharmaceutical company used creative internal accounting and predatory financial tactics to charge higher prices for drugs while also promoting the practice of filling prescriptions with very expensive drugs it controlled when generic drugs likely would have been the same. The result is insurance companies paid billions more than needed, which at least in theory forces health costs up for all of us. The stock is down about 90% from its peak in August, and this week its CEO Michael Pearson was forced to resign.

An interesting difference with Enron is that Valeant is technically domiciled in Canada and so is not in S&P 500 funds or most US mutual funds. It is however, an important holding in many hedge funds – most prominently that of Bill Ackman, a good looking billionaire who ironically is also famous for shorting and attacking Herbalife as a Ponzi scheme and now finds himself on the Valeant board. His main fund is down around 25% this year. John Paulson got stung, as did the Sequoia fund, run by Buffett disciple Ruane Cuniff, who was forced to resign this week over Valeant-driven poor performance.

It is a complex story with interesting characters – someday there will no doubt be a movie made. But from an investing perspective, it is a simple example of the risks of concentrated holdings. If you have a single stock that represents a big chunk of your net worth there is a non-zero chance it will implode. No one expected Enron or Lehman or Bear Stearns or…… to get wiped out. Valeant is still alive, but on life support. Highly unpleasant but still less extreme examples, including solid companies such as LinkedIn being down 50% this year, are even more common.

Valeant is also an example of the benefits of rebalancing. Despite a disastrous six months, Valeant is trading about where it did for much of 2011. If you bought stock near the bottom of the bear market in 2008 and never sold, you’d still be up 400%. And if you had bought any time before 2013 and periodically took some profits in the form of rebalancing and allocating to areas of your portfolio which were not doing well, Valeant would have been very, very kind to you.

The content contained in this blog post is intended for general informational purposes only and is not meant to constitute legal, tax, accounting or investment advice. You should consult a qualified legal or tax professional regarding your specific situation. Keep in mind that investing involves risk. The value of your investment will fluctuate over time and you may gain or lose money.

Any reference to the advisory services refers to Personal Capital Advisors Corporation, a subsidiary of Personal Capital. Personal Capital Advisors Corporation is an investment adviser registered with the Securities and Exchange Commission (SEC). Registration does not imply a certain level of skill or training nor does it imply endorsement by the SEC.

Craig Birk leads the Personal Capital Advisors Investment Committee and serves as Chief Investment Officer. His focus is translating improvements in technology into better financial lives. Craig has been widely quoted in the Wall Street Journal, Bloomberg, CNN Money, the Washington Post and elsewhere. Prior to Personal Capital Advisors, he was a leader within the portfolio management team at Fisher Investments, helping assets under management grow from $1.5 billion to over $40 billion. Craig graduated from the University of California at San Diego and has earned the Certified Financial Planner® designation.
Icon Close

To learn what personal information Personal Capital collects, please see our privacy policy for details.

Let us know…

This year, my top financial priority is:

Building my emergency fund
Paying off high-interest debt
Budgeting better
Saving for a short-term goal, like a vacation or new car
Increasing my investment contributions
Maintaining status quo - I’ve got this under control

Make moves toward your money goals with Personal Capital’s free financial tools.